ACADIA Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	957.8	726.44	517.24	484.15	441.76	Upgrade
Revenue Growth (YoY)	31.85%	40.45%	6.83%	9.60%	30.28%	Upgrade
Cost of Revenue	385.09	393.26	371.74	258.56	286.88	Upgrade
Gross Profit	572.71	333.18	145.49	225.59	154.88	Upgrade
Selling, General & Admin	488.43	406.56	369.09	396.03	388.66	Upgrade
Operating Expenses	488.43	406.56	369.09	396.03	388.66	Upgrade
Operating Income	84.28	-73.38	-223.6	-170.44	-233.79	Upgrade
Interest & Investment Income	25.46	17.23	6.61	0.59	6.61	Upgrade
Other Non Operating Income (Expenses)	1.82	-	-	-	-	Upgrade
EBT Excluding Unusual Items	111.56	-56.15	-216.99	-169.85	-227.18	Upgrade
Merger & Restructuring Charges	-	-	-	-	-52.8	Upgrade
Gain (Loss) on Sale of Investments	-	5.11	3.54	2.33	-1	Upgrade
Gain (Loss) on Sale of Assets	146.52	-	-	-	-	Upgrade
Pretax Income	258.08	-51.04	-213.44	-167.52	-280.97	Upgrade
Income Tax Expense	31.62	10.25	2.53	0.35	0.61	Upgrade
Net Income	226.45	-61.29	-215.98	-167.87	-281.58	Upgrade
Net Income to Common	226.45	-61.29	-215.98	-167.87	-281.58	Upgrade
Shares Outstanding (Basic)	166	164	162	160	157	Upgrade
Shares Outstanding (Diluted)	166	164	162	160	157	Upgrade
Shares Change (YoY)	1.55%	1.32%	0.74%	2.01%	6.88%	Upgrade
EPS (Basic)	1.37	-0.37	-1.34	-1.05	-1.79	Upgrade
EPS (Diluted)	1.36	-0.37	-1.34	-1.05	-1.79	Upgrade
Free Cash Flow	157.2	16.65	-114.04	-126.78	-143.75	Upgrade
Free Cash Flow Per Share	0.94	0.10	-0.70	-0.79	-0.91	Upgrade
Gross Margin	59.79%	45.87%	28.13%	46.59%	35.06%	Upgrade
Operating Margin	8.80%	-10.10%	-43.23%	-35.20%	-52.92%	Upgrade
Profit Margin	23.64%	-8.44%	-41.76%	-34.67%	-63.74%	Upgrade
Free Cash Flow Margin	16.41%	2.29%	-22.05%	-26.19%	-32.54%	Upgrade
EBITDA	100.16	-67.83	-221.57	-167.1	-230.85	Upgrade
EBITDA Margin	10.46%	-9.34%	-42.84%	-34.51%	-52.26%	Upgrade
D&A For EBITDA	15.88	5.55	2.03	3.34	2.93	Upgrade
EBIT	84.28	-73.38	-223.6	-170.44	-233.79	Upgrade
EBIT Margin	8.80%	-10.10%	-43.23%	-35.20%	-52.92%	Upgrade
Effective Tax Rate	12.25%	-	-	-	-	Upgrade
Revenue as Reported	957.8	726.44	517.24	484.15	441.76	Upgrade
Advertising Expenses	21.1	9.4	5.5	41.8	51.1	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q